“The microbiome is a mirror of society. Are we ready to look?”

From ultra-processed food to childhood adversity, the forces that disrupt the gut microbiome extend far beyond medicine, says professor Antonio Gasbarrini

“Doctors cannot solve this problem alone. If the microbiome is shaped by education, food systems, environmental conditions and social circumstances, then protecting the microbiome must also involve education, agriculture, public health and economic policy.”

These are the words of Antonio Gasbarrini, Professor of Internal Medicine at Università Cattolica del Sacro Cuore in Rome, shared with The Cormoran in an interview following the publication of his latest article, The Microbial Mirror: How an Altered Microbiome Predicts Disease and Why Policy Must Act, co-authored with Gianluca Ianiro and Giovanni Gasbarrini and published in Nature Reviews Gastroenterology & Hepatology.

Professor Gasbarrini, your latest article makes a striking claim: the gut microbiome may tell us not only how healthy we are today, but also what diseases we may be at risk of developing tomorrow. Are we really approaching that point?
We are on the brink of a profound shift in the way we think about health. The gut microbiome is shaped by almost every aspect of our lives: what we eat, how we sleep, how physically active we are, the stress we experience, the medications we take, and the environment in which we live. In that sense, the microbiome can be regarded as a biological record of our life history. It reflects the consequences of many environmental exposures. Because some of these alterations may occur long before a disease becomes clinically apparent, the microbiome may offer us a window into our future health. The ambition is not to predict the future with absolute certainty. It is to recognise biological trajectories early enough to modify them.

Your article calls the microbiome a “mirror”. What exactly is it reflecting?
It reflects, at least in part, the world we have built around ourselves. Our food systems, lifestyles, environmental exposures and even social inequalities can leave a biological imprint on the gut ecosystem. The microbiome therefore represents one of the interfaces connecting biology with society. It reminds us that chronic disease is rarely the result of isolated individual choices alone. Rather, it often emerges from the cumulative interaction between an individual’s biology and the environment over many years. That is why the microbiome may help us see the bigger picture—and potentially intervene before damage becomes clinically visible.

You argue that modern medicine often arrives too late. What do you mean?
In many cases, it does. Modern medicine is extraordinarily effective at treating established disease, but we still tend to intervene when the disease has already become clinically visible. Noncommunicable diseases often develop over many years or even decades. The diagnosis may therefore represent the final chapter of a much longer biological story. The microbiome gives us an opportunity to look upstream. Instead of asking only, “How do we treat diabetes, cardiovascular disease or cancer?”, we should also be asking, “Which biological processes began years before the diagnosis?” That is the real promise of prevention: not simply detecting disease earlier, but understanding-and, where possible, interrupting- the processes that make disease possible.

One of those processes is “meta-inflammation”. Why should people care about it?
Because it may be one of the hidden links between our daily exposures and the diseases we eventually develop. Meta-inflammation is a persistent, low-grade inflammatory state. It is very different from the acute inflammation we recognise when we have a fever or an infection. It may operate silently, below conventional clinical detection thresholds, while progressively influencing metabolic, immune and even neurological pathways. A disrupted microbiome can contribute to this process. When beneficial microbial functions are lost and intestinal barrier integrity is impaired, microbial products may translocate across the gut barrier and promote chronic low-grade inflammation. Over time, these effects may accumulate. The biological damage may begin long before disease becomes clinically apparent.

Your article focuses particularly on ultra-processed foods. What is the main concern?
The discussion about food has traditionally focused on calories and individual nutrients. These remain extremely important, but they are not the whole story. A growing body of experimental and epidemiological evidence suggests that ultra-processed foods, as well as certain food additives, may disrupt the intestinal ecosystem, alter the mucus layer and intestinal barrier, and promote low-grade inflammation. The microbiome may therefore be influenced not only by which nutrients we consume, but also by how food is produced, formulated and processed. Some additives and combinations of additives may have biological effects that are not fully captured by traditional nutritional or toxicological assessment. This should have regulatory implications.

What kind of implications?
Food-additive safety assessments should increasingly incorporate standardised and validated measures of their potential effects on the microbiome. We cannot continue evaluating substances while systematically overlooking a major biological ecosystem that may be directly affected by them and that may, in turn, influence pathways relevant to noncommunicable diseases. We should also investigate the cumulative and combined effects of mixtures of additives that people consume in everyday life, rather than studying each substance exclusively in isolation. And we need to reconsider the traditional separation between nutritional guidance and food-safety assessment. A food product should not automatically be regarded as biologically neutral simply because it complies with conventional nutritional and toxicological criteria, particularly when its effects on the gut ecosystem have not been adequately characterised.

That takes the conversation well beyond the hospital.
Absolutely. We need to think about prevention across the whole of society. That includes better nutritional education, policies that facilitate access to minimally processed foods, appropriate antibiotic stewardship, preventive healthcare programmes, and sustained investment in research. Health economics is also essential. As long as healthcare systems predominantly reward the treatment of established disease rather than supporting prevention across the life course, preventive health will inevitably remain marginal. Doctors cannot solve this problem alone. If the microbiome is shaped by education, food systems, environmental conditions and social circumstances, then protecting the microbiome must also involve education, agriculture, public health and economic policy.

You also draw a connection between childhood adversity and future disease. Why is early life so important?
Because early life is a critical period during which biological systems are being established and shaped. Adverse experiences during childhood may have long-term effects on the gut ecosystem and on immune, metabolic and neuroendocrine regulation, potentially increasing vulnerability to later environmental stressors. In other words, early-life experiences may contribute to biological susceptibility that only becomes clinically apparent decades later. That should influence the way we think about prevention. Child protection, poverty reduction, education and adequate housing may sound like social policies rather than medical interventions. Yet if they help reduce the biological conditions that favour chronic disease, they should also be recognised as public-health interventions.The microbiome makes the traditional separation between social policy and health increasingly difficult to defend. Social conditions can become biology. The same reasoning applies to nutrition. Repeated exposure to unhealthy dietary patterns, including a high intake of ultra-processed foods during childhood and adolescence, may contribute to biological trajectories associated with chronic noncommunicable diseases later in life.

You call this approach “ecological medicine”. What does that mean?
Ecological medicine does not replace molecular medicine, genomics or precision medicine. It adds a dimension that has too often been missing: the ecological dimension of human health. We are not isolated organisms. We live in constant interaction with microbial ecosystems and with the wider environment. Ecological medicine seeks to understand those interactions and how they evolve over time. In practice, it means considering the microbiome as a meaningful component of health, integrating microbiome data with clinical, metabolic, immune and genomic information, while also recognising the environmental factors that shape those biological systems. The ultimate goal is to move towards anticipatory medicine.

Is the microbiome already becoming a medical target?
Yes. Microbiome-based approaches are already a clinical reality in some areas, most notably in the prevention and treatment of recurrent Clostridioides difficile infection, and the field is moving well beyond the traditional concept of probiotics. We are seeing increasingly sophisticated strategies, including faecal microbiota transplantation and rationally designed live biotherapeutic products. There are also important developments in oncology, where the microbiome appears capable of influencing responses to immunotherapy, although many of these approaches are still under investigation and require further clinical validation. But the most important transformation may ultimately be broader: using the microbiome not only to treat disease, but also to identify biological risk, monitor trajectories and preserve health.

What is the single biggest change you would like to see?
I would like to see prevention move from the margins to the centre of medicine. The best time to intervene is before a patient becomes ill. This means investing in healthier environments, healthier food systems and earlier forms of prevention throughout the life course. One concrete example is reducing, as much as reasonably possible, the consumption of ultra-processed foods among children and young people and promoting access to healthier, minimally processed alternatives. The microbiome offers us a new way of understanding this challenge. It is both a living ecosystem and, in many respects, a biological record of our life experiences. And perhaps that is its most powerful lesson: if the microbiome is a mirror, then we should have the courage to look at what it is showing us-and to reshape the world it reflects.

Most viewed

In Lebanon a small wheat harvest sparks a bigger idea

Lebanon imports about 80 per cent of its wheat. In Beirut, farmers and a sourdough baker grow their own grain, testing a local path to food sovereignty.

The Cormoran takes flight: thinking beyond the headlines

The Cormoran, a European think tank born in Italy, sets out its mission: evidence-based analysis for EU citizens and policymakers, beyond the news cycle.

The endless reinvention of junk food

The processed food industry tweaks recipes and borrows wellness language to calm public alarm. Michael Moss explains why only regulators can end the game.